ExpertED@SSO: Premiere Education for Cancer Surgeons
Adjuvant Therapy in High Risk Melanoma
Plan to attend the webinar, “Adjuvant Therapy in High Risk Melanoma,” on December 13, 2018 at 5:00 pm EST with faculty Richard White, Jr., MD, Genevieve Boland, MD, PhD, Mary Sue Brady, MD and Jeffrey Sosman, MD. The staging of melanoma has changed and has impact on care decisions, which have evolved across disease stages. Participants in this program will be better able to identify changes in the staging system and understand adjuvant treatment options and proper indications related to BRAF negative patients.